Pharmabiz10h
US FDA approves BeiGene’s Tevimbra in combination with chemotherapy for first-line treatment of gastric and gastroesophageal junction cancers
San Mateo, California Monday, December 30, 2024, 18:00 Hrs [IST] ...
Pharmabiz11h
Huadong Medicine & SynerK ink strategic cooperation to jointly develop novel siRNA drug SNK-2726 targeting AGT to treat hypertension
Huadong Medicine & SynerK ink strategic cooperation to jointly develop novel siRNA drug SNK-2726 targeting AGT to treat hypertension: Suzhou, China Monday, December 30, 2024, 17:0 ...
Pharmabiz12h
IDEAYA Biosciences inks license agreement with Hengrui Pharma for SHR-4849, a novel DLL3 Topo-I-payload ADC targeting SCLC and NET solid tumours
South San Francisco, California Monday, December 30, 2024, 16:00 Hrs [IST] ...
Pharmabiz12h
Researchers develop method for detecting H. pylori and mutations for rural India
A group of researchers have found a way to develop FNCAS9 Editor Linked Uniform Detection Assay (FELUDA), a test developed during the Covid-19 period to diagnose Covid cases, as a point-of-care ...
Pharmabiz13h
Festive season brings elevated risks of respiratory illnesses, cautions Dr Kate O’Reilly
Festive season brings elevated risks of respiratory illnesses, cautions Dr Kate O’Reilly: Our Bureau, Mumbai Monday, December 30, 2024, 15:00 Hrs [IST] As the festive period app ...
Pharmabiz13h
TN health minister felicitated new director of the DCA, M Sridhar, at a function organized by state IPA branch
TN health minister felicitated new director of the DCA, M Sridhar, at a function organized by state IPA branch: Our Bureau, ...
Pharmabiz14h
argenx’s Vyvdura receives Japanese regulatory approval for adults with chronic inflammatory demyelinating polyneuropathy
Vyvdura receives Japanese regulatory approval for adults with chronic inflammatory demyelinating polyneuropathy: Rotterdam, the Netherlands Monday, December 30, 2024, 1 ...
Pharmabiz14h
Diagnostic testing sector shaping the future of healthcare in India: Study
India's diagnostic testing industry has seen a transformative evolution over the last five years with significant shifts in test volumes, adoption rates and regional growth patterns. Metropolitan ...
Pharmabiz14h
MDC defers decision on Para 32 exemptions owing to lack of action from DPIIT
Delay from the Department for Promotion of Industry and Internal Trade (DPIIT) in nominating an eligible representative from the patent office is forcing the Multidisciplinary Committee of Experts ...
Pharmabiz15h
Sensorion completes enrollment of the first cohort of the Audiogene phase 1/2 gene therapy clinical trial
Montpellier, France Monday, December 30, 2024, 13:00 Hrs [IST] ...
Pharmabiz16h
PharmaTech Expo & LabTech Expo to be held in Bengaluru from Jan 8 to 10, 2025 at BIEC with KDPMA as associate partner
Our Bureau, Bengaluru Monday, December 30, 2024, 12:00 Hrs [IST] ...
Pharmabiz17h
US FDA approves Opdivo Qvantig injection, for subcutaneous use in most previously approved adult, solid tumour Opdivo indications
US FDA approves Opdivo Qvantig injection, for subcutaneous use in most previously approved adult, solid tumour Opdivo indications: Princeton, New Jersey Monday, December 30, 2024, ...